Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rapamune Whistleblower Suit Gets Jolt From Government Intervention

This article was originally published in The Pink Sheet Daily

Executive Summary

The Department of Justice has intervened in a qui tam suit alleging Wyeth promoted the immunosuppressant for off-label uses and offered kickbacks to providers. Settlement now seems more likely.
Advertisement

Related Content

Pfizer On Track To Settle Rapamune Investigation; Protonix Probe Still Unresolved
No End In Sight: Pharma Companies Continue To Face Government Probes
No End In Sight: Pharma Companies Continue To Face Government Probes
Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive
Qui Tam Litigation: Peter Rost Suit Fails As Others Thrive

Topics

Advertisement
UsernamePublicRestriction

Register

PS071211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel